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Abstract—Instabilities in ventricular repolarization have been
documented to be tightly linked to arrhythmia vulnerability.
Translation of the information contained in the repolarization
phase of the ECG into valuable clinical decision-making tools
remains challenging. This work aims at providing an overview
of the last advances in the proposal and quantification of
ECG-derived indices that describe repolarization properties and
whose alterations are related with threatening arrhythmogenic
conditions. A review of the state-of-the-art is provided, spanning
from the electrophysiological basis of ventricular repolarization
to its characterization on the surface ECG through a set of
temporal and spatial risk markers.
Index Terms—Electrophysiological basis of the ECG, ECG
waves, ECG intervals, repolarization instabilities, spatial and
temporal ventricular repolarization dispersion, cardiac arrhyth-
mias, biophysical modeling of the ECG, ECG signal processing,
repolarization risk markers, T wave alternans, QT variability.
I. INTRODUCTION
Since its invention by Willem Einthoven (1860-1927) the
electrocardiogram (ECG) has become the most widely-used
tool for cardiac diagnosis. The ECG describes the electrical
activity of the heart, as recorded by electrodes placed on
the body surface. This activity is the summed result of the
different action potentials (APs), concurring simultaneously,
from all excitable cells throughout the heart as they trigger
contraction. The trace of each heartbeat in the ECG signal
consists on a sequence of characteristic deflections or waves,
whose morphology and timing convey useful information to
identify disturbances in the heart’s electrical activity.
The timing of successive heartbeats [1] or wave shape pat-
terns, the coupled relationship between parameters associated
with those patterns, their evolution over time, their responses
to heart rate changes, their spatial distribution, etc, may
provide useful information about the underlying physiological
phenomena under study, which become the driving forces for
the methodological developments of ECG signal processing
[2].
The lead system, or body locations where the electrodes
are located for ECG acquisition, are usually standardized.
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Fig. 1. Left panel, the standard 12-lead ECG. The ECG corresponds to a
healthy subject. Central panel: a vectorcardiographic loop and its projection
onto the three orthogonal planes. Right panel: the orthogonal vectorcardio-
graphic leads. Adapted from [3].
This facilitates inter-subject and serial comparison of measure-
ments. The conventional lead systems are the 12-lead system,
typically used for recordings at rest, and the orthogonal lead
system, whose three leads jointly form the vectorcardiogram
(VCG), and which can be either directly recorded or derived
from the 12 standard leads, see Fig. 1. There is a large
bibliography dealing with the basis of electrocardiography [1]
and basis combined with signal processing [3]. In addition to
resting ECG, several other lead systems, depending on the
purpose of the exploration, can be found. To name some,
we refer to intensive care monitoring, ambulatory monitoring,
stress test, high resolution ECG, polysomnographic recordings,
etc.
The ECG can be viewed as spatio-temporal integration of
the APs associated with all of the cardiac cells [3], [4] (see
Fig. 2). Fig. 3 shows a cardiac cycle, illustrating the most
relevant ECG waves. The T wave is the one that reflects ven-
tricular repolarization. Instabilities in ventricular repolarization
have been documented to be tightly linked to arrhythmia
development [5], thus justifying the interest in the analysis
and review of methods dealing with T wave characterization
and quantification. The present paper follows from a previous
review on cardiac repolarization analysis by the same authors
[6].
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Fig. 2. Morphology and timing of APs from different regions of the heart
and the related cardiac cycle of the ECG. Adapted from [3].
Sudden cardiac death (SCD) is a major cause of death
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Fig. 3. ECG of two cardiac cycles and most relevant intervals and waves.
in developed countries, where 1 out of 1000 subjects die
every year due to SCD [7]. This is about 20% of all deaths,
which underscores the importance of its prevention [8]. Ven-
tricular arrhythmias, such as ventricular tachycardia (VT) or
ventricular fibrillation (VF), are the cause of most SCDs [9],
whereas only a small percentage of cases of SCD are due to
bradycardia.
Three main factors have been identified to have a major role
in the initiation and maintenance of arrhythmias: substrate,
triggers and modulators. A vulnerable myocardium is the
substrate for arrhythmogenesis, meaning that when triggering
factors appear, they can lead to malignant arrhythmias poten-
tially ending in SCD. Increased dispersion of the repolarization
properties among different ventricular myocardial cells or
regions has been identified as a characteristic of a vulnerable
substrate [10]. Other factors can modulate the arrhythmogenic
substrate or the triggers by altering the electrophysiological
properties of the heart. An important modulator is the auto-
nomic nervous system (ANS) [11].
Therapeutic choices designed to treat cardiac arrhythmias,
and eventually prevent SCD, are highly conditioned by the
factors (substrate, triggers and modulators) that contribute to
their generation. Implantable cardioverter defibrillators (ICDs)
are designed to apply an electric shock to the heart in the
presence of VT or VF and restore its sinus rhythm. Antiar-
rhythmic drugs, by acting on some of those factors, prevent
the occurence of arrhythmias, thus reducing the probability of
SCD. The use of these therapies (or a combination of them)
must be assessed in terms of safety for the patient and cost-
effectiveness. This justifies the importance and necessity of
developing strategies to identify high-risk patients who would
benefit from a specific therapy.
Repolarization analysis based on the ECG is a low-cost,
non-invasive approach that has been shown to be useful
for risk assessment [6] and can be applied to the general
population. Currently, challenges in this matter involve better
understanding of the electrophysiological bases responsible
for or secondary to the development of an arrhythmogenic
substrate. When this better knowledge is paired with better
understanding of the transformation from cellular electrical
activity to surface ECG, then better targeted ECG-based risk
stratification markers may become available.
In section II-A of this paper, the ionic and cellular bases
of ECG repolarization patterns under physiological conditions
are presented and in section II-B, under pathological con-
ditions as the basis for translation of cellular signatures to
the surface ECG. In section II-C a method for biophysical
representation of tissue properties and its correspondence into
the ECG [12] is also presented, which can be useful when
global myocardium property distributions are in need for
ECG interpretation and risk identification. In section III-A
basic concepts of ECG signal processing are described. In
section III-B ECG features characterizing the spatial varia-
tion of repolarization are reviewed. Section III-C explores
ECG measurements and morphological markers describing
temporal variability of ventricular repolarization, including the
dynamics of QT dependence on heart rate (HR). Section III-D
introduces T wave alternans and other novel ECG indices
integrating spatial and temporal dynamics of ventricular repo-
larization. Challenges and future perspectives on ECG-based
repolarization assessment are presented in section IV. Finally,
conclusions are presented in section V.
II. ELECTROPHYSIOLOGICAL BASIS OF REPOLARIZATION
INSTABILITIES
A. Repolarization waveforms
1) Membrane currents and AP: Establishing a relationship
between ECG and AP properties can prove fundamental for
a better understanding of the mechanisms underlying cardiac
arrhythmias. The AP associated with each cardiac cell is the
result of ion charges moving in and out of the cell through
voltage-gated channels. A representative AP of a ventricular
myocyte is presented in Fig. 4a. Phases 0-4 in the AP can
be appreciated, with different currents through ion channels
and electrogenic transporters contributing to each of them
(Fig. 4b). Some of those currents are notably differently
expressed across the ventricles.
In the last years, mathematical models have been proposed
to describe electrical and ionic homeostasis in human ventric-
ular myocytes. A relevant model of human ventricular AP was
proposed by Iyer et al. [13], reproducing diverse aspects of the
excitationcontraction coupling. One of the most widely used
models is the one proposed by ten Tusscher & Panfilov [14].
Later, another model of human ventricular AP was proposed
by Grandi et al. [15], which was subsequently modified to
accurately reproduce arrhythmic risk markers recorded in
experiments [16]. The O’Hara et al. model is the most up-
to-date model of a human ventricular myocyte [17].
Fig. 4. a) Action potential of a ventricular myocyte, with indication of its
phases. b) Ionic currents underlying the different AP phases are illustrated.
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3Fig. 5. Outline of a simulation, where the recorded ECG, the simulated
Pseudo-ECG, the real myocardium and a simulated setup, are used for
comparison of simulated and recorder markers (see section III-D2). In this case
a 2D tissue slice with a particular cell type distribution across the ventricular
wall is used. Crossed arrow shows a desirable but unaccessible connection.
Tasks 1, 2 and 3 represent the different comparison tasks that can be done.
Reproduced from [20].
2) Intrinsic heterogeneities: Differences in repolarizing
currents have been documented between anterior, inferior and
posterior walls of the left ventricle, and also between apex
and base [18]. Transmural differences exist as well, with
endocardial, midmyocardial and epicardial cells having been
described. Most mathematical models of human ventricular
electrophysiology account for such heterogeneities. Intrinsic
ventricular heterogeneities are essential for cardiac function
under normal physiological conditions.
3) Genesis of ECG repolarization waves and intervals:
The T wave of the ECG reflects heterogeneities in ventricular
repolarization, see Fig. 2. Its formation depends both on the
sequence of ventricular activation and on the heterogeneities
in AP characteristics throughout ventricular myocardium [19].
The QT interval of the ECG, measured from QRS onset to
T wave end, has been used in most repolarization studies.
It represents the time needed for ventricular depolarization
plus repolarization and it is closely related to the AP duration
(APD) of ventricular cells.
From the knowledge of the electrical activity at the cellular
and tissue levels, one can approach the issue of simulating
ECG signals based on a specified spatial distribution of cells
within the myocardium and considering a particular excitation
pattern. 1D, 2D or 3D tissue models can be generated, where
geometry, anisotropy, connectivity, propagation velocity etc,
need to be taken into account. Additionally, modeling of
the torso leads to more accurate simulation of surface ECG
signals. One schematic example of this process can be seen in
Fig. 5.
B. Abnormal repolarization and cardiac arrhythmias
1) Pathological heterogeneities: Many cardiac pathologies
accentuate intrinsic heterogeneities in ventricular repolariza-
tion. Pathological states associated with enhanced repolar-
ization heterogeneities include ischemia, Brugada syndrome,
long QT syndrome (LQTS) or heart failure. In section III-B1
methods to quantify dispersion of repolarization from surface
ECG time intervals will be described. In section III-B2 meth-
ods used to evaluate electrocardiographic T wave morphology
changes, as a reflection of amplified heterogeneities in AP
repolarization, will be presented.
In addition to spatial heterogeneities, increased temporal
repolarization heterogeneities have been as well linked to
proarrhythmia. A phenomenon associated with temporal re-
polarization heterogeneity is abnormal APD adaptation in
response to cycle length changes, which has been suggested
to play a role in the genesis of arrhythmias [21]. Evalua-
tion of ECG repolarization adaptation to HR changes will
be presented in section III-C1. Another phenomenon is AP
variability, measured as fluctuations in the duration of the AP,
which has been closely linked to SCD under different con-
ditions [22]. QT variability quantified from the surface ECG
can be considered as an approximation to the study of such
phenomenon and it will be explored in section III-C2. Section
III-D1 will examine T wave alternans (TWA), which have been
shown to be proarrhythmic in different investigations [23].
TWA is considered as a manifestation of spatial or temporal
dispersion of repolarization [24]. AP alternans, defined as
changes in AP occurring on an every-other-beat basis, can
be a basis for TWA. Ischemia, extrasystoles or a sudden
HR change may cause discordant (spatially unsynchronized)
alternans and unidirectional block, thus setting the stage for
ventricular arrhythmias like VF [24].
Ventricular dispersion properties at different HRs are usually
quantified by the so-called dynamic APD restitution curves
(APDR). These curves, see Fig. 13 left panel, express the APD
as a function of the RR interval (inverse of HR) for different
regions within the myocardium. In experimental, clinical and
computational studies, it has been shown that an increase
in APDR dispersion is associated with greater propensity to
suffer from VT/VF, the most common sequence to SCD [25],
[26]. Other studies have reported differences in transmural
heterogeneity at different cycle lengths between end-stage
failing and non-failing human ventricles [27]. When com-
pared to non-failing hearts, end-stage failing hearts presented
significantly decreased transmural APD gradients between
the subendocardium and subepicardium. All these evidences
highlight the challenge of identifying surface ECG surrogates
of this APDR dispersion present at cellular and tissue levels.
Some of those will be reviewed in sections III-D2 and III-D3,
together with their capacity for arrhythmia prediction.
Cardiac arrhythmias can be caused by abnormalities in
impulse formation, impulse conduction, or both, as further
detailed in the following section.
2) Abnormalities of impulse generation:
a) Automaticity: Abnormal automaticity occurs when
cells other than those in the sino-atrial (SA) node undertake its
function. Certain forms of VT arise due to such abnormalities.
Under pathological conditions, the SA node cells may reduce
their rate of spontaneous depolarization or even lose their
property of automaticity.
b) Afterdepolarizations and triggered activity: If, under
normal SA node functioning, other cells develop rates of firing
faster than those of the SA node, new APs are initiated in those
cells and their adjacent ones. This triggered activity can be the
4result of the formation of early afterdepolarizations (EADs,
second depolarizations occurring during AP repolarization)
or delayed afterdepolarizations (DADs, occurring after AP
repolarization). A good number of investigations have pointed
to EADs playing a role in the initiation and perpetuation of the
polymorphic VT known as Torsades de Pointes (TdP) [28].
3) Abnormalities of impulse conduction: Abnormal im-
pulse conduction may lead to reentry, where a circuitous
wavefront reexcites the same tissue indefinitely. Unidirectional
conduction block and slow conduction are required for reentry
to occur. VF is an example of re-entrant arrhythmia.
C. Biophysical modeling of the ECG
In this section we describe a modeling approach that
considers the myocardium as a volume conductor with two
surfaces uniformly bounding the whole ventricular tissue, also
known as Uniform Double Layer (UDL) [29], giving raise to
the Dominant T wave concept [12]. This is derived from an
analysis of the electrical properties of the ventricle treated
as a homogeneous syncytium by means of the bidomain
approach [30]. This approach assumes that the myocardial
tissue is formed by two separate domains, the intracellular and
the extracellular spaces, sharing the same volume [31]. Both
domains behave as regular volume conductors and, therefore,
two potentials are defined at each point.
The bidomain model is commonly employed in large-scale
simulations with different applications. Here our interest is
in obtaining the potential recorded at the body surface [30].
This results in an inhomogeneous volume conductor problem
constituted by the torso with the ventricular cavities. In the
frequency range of interest (≤ 1000 Hz), the potential x(t)
recorded at a given unipolar ECG can be written as
x(t) = −
∫
H
ci (∇vφm(v, t) ∙ ∇vZ(v)) dv (1)
where φm(v, t) is the transmembrane potential (TMP) (dif-
ference of potential between the inside and the outside of the
cell), ci is the inner domain conductance tensor, and ∇vZ(v)
is the transfer impedance function, which relates current dipole
ci∇vφm(v, t) in the volume dv with its contribution to
the potential in the unipolar lead. These contributions are
integrated over the heart volume H, coordinated by v. When
both domains have the same anisotropy ratio, equation (1) is
equivalent [32] to the surface integral
x(t) = −
∫
S
ci φm(s, t) (∇vZ(s) ∙ d~s) (2)
where S is the surface, coordinated by s, enclosing the active
regions of the heart (endocardium, epicardium and septum).
Although the cardiac tissue does not satisfy well the condition
of equal anisotropy, it has been shown for 2D cardiac tissue
[33] that the approximation essentially holds, except in the
neighborhood of the activation site.
According to (2), the potential x(t) can be obtained by
integrating only over the surface S . Therefore, we can replace
the active sources in the heart by a dipole layer on S , with
a moment proportional to φm(t) without affecting x(t). This
equivalence, linking the potential measured in a lead with the
TMP at the surface S is usually called (equivalent) surface
source model.
Dominant T wave formalism: In [29], van Oosterom pointed
out that using equation (2) to obtain body surface T waves
from the electrical activity in the heart is equivalent to evaluate
a linear system for each time. The surface of the heart can
be divided into M contiguous regions (called nodes), where
each node is treated as a single lumped source. Considering L
surface leads, equation (2) can be approximated, at any instant
t, by[
x1(t), . . . , xL(t)
]T = x(t) = A [φ1(t), . . . φM (t)]T (3)
where x(t) is a column vector with the L potentials, and
A is an L × M transfer matrix, invariable for a given lead
configuration and patient, and accounting for the geometry and
conductivity of the volume conductor, as well as for the solid
angles under which each node contributes to the potentials in
x(t). In the rest of this work, we will use φm(t) to describe the
repolarization phase of the equivalent TMP of a given region
m. Note that the sum of the M elements of each row of matrix
A must be zero (i.e. Ae1 = 0, where e1 and is an M × 1
vector of ones and 0 is a L×1 vector of zeros). This property
shows that a T wave in the surface ECG is only possible if
φm(t) differs between regions. As stated in [29], eq. (3) allows
to link the shape of the T wave in each lead to the different
TMPs. If we further assume that the different φm(t) have the
same shape and only differ in the time of repolarization time
(RT ) ρm, i.e., φm(t) = d(t − ρm), where ρm is defined as
the time with maximum downslope of the TMP d(t), then, as
proposed in [34],
x(t) = A
[
d(t− ρ1), . . . , d(t− ρM )
]T
. (4)
This approximation essentially assumes that the TMP downs-
lope shape is approximately constant across the heart surface.
Expressing the RT of each node as [34]
ρm = ρ + Δρm, (5)
where ρ=
∑M
m=1 ρm/M , when Δρm ¿ ρ the TMP shape d(t)
can be expanded in series around ρ as
d(t− ρm) = d(t− ρ)−Δρm dd(τ)
dτ
∣∣∣∣
τ=t−ρ
+
Δρ2m
2!
d2d(τ)
dτ2
∣∣∣∣
τ=t−ρ
+ o(Δρ3m). (6)
Since Ae1D(t− ρ) = 0 and neglecting higher order terms,
the model (4) can be approximated as
x(t) ≈ −A Δρ d˙(t− ρ) (7)
with Δρ = [Δρ1, Δρ2, ..., ΔρM ]T , or in discrete time
X ≈ w1tTd (8)
where w1 = −A Δρ is an L× 1 vector of the so-called lead
factors, X is an L×N matrix with the sampled signals at the
surface leads and the N × 1 vector td is a sampled version
of td(t) = d˙(t − ρ). The vector −td was given the name
of dominant T wave by van Oosterom [35]. Note that if the
approximation in (7) holds, all T waves measured on different
5leads are just a scaled version of td. Methods to estimate td
and w1 can be found in [34], [35].
This approximated modeling to derive the T wave can
be adapted to situations with increased dispersion of the
RT s, as it happens in patients with increased vulnerability
to ventricular arrhythmias [36]. In that case, the second order
contribution in (6) becomes relevant and the following second-
order approximation of (4) can be used:
x(t) ≈ −A Δρ d˙(t− ρ) + 1
2
A Δρ2 d¨(t− ρ) (9)
X ≈ w1tTd + w2t˙Td (10)
where w2 = 12A Δρ
2 is a set of second-order lead factors
and Δρ2 = [Δρ21, Δρ22, ..., Δρ2M ]T . One example of the
d(t − ρm), m = 1,...,M and the T waves generated with the
methodology is depicted in Fig. 6. For this model to be used,
we need to estimate both td and the lead vectors w1 and w2,
from the original data X.
Lead factor estimation: One simple option to estimate the
dominant T wave td is as the average of all the T waves
weighted by their integral [35],
tTd = c1 e
T
1 X
T X (11)
and multiplying equation (8) by e1 we obtain
w1 =
Xe1
tTd e1
, (12)
which is a close expression for the first order approximation
lead factor w1. The scalar c1 (11) is defined as in [34]. Another
alternative is to estimate the dominant T wave as the first
principal component (PCA) of the T waves by doing a PCA
decomposition in time [37] of the T wave matrix X. This can
be done equivalently by singular value decomposition (SVD)
[38], [39]:
X = UΛVT =
L∑
l=1
ulλlvTl (13)
resulting in
tTd = c2λ1v
T
1 , w1 = u1/c2 (14)
which if λ1 À λl 6=1 can be proved [34] to be equivalent
to T wave averages. c2 is defined as in [34]. This SVD-
based estimate can be shown to be optimum in the sense
of minimizing the Frobenius norm ²1 =
∥∥X−w1tTd ∥∥F .
The second order approximation can be done as in [34] by
minimization of the norm ²2 =
∥∥X−w1tTd −w2t˙Td ∥∥F .
However, other alternatives exist by realizing that minimizing
²2 reduces to minimizing ²1 by considering now (X−w1tTd )
as the X in ²1 and w2t˙Td as the w1tTd . In such a case t˙Td
becomes proportional to the first eigenvalue of (X − w1tTd ),
which since w1tTd is already the first component of X then
it becomes evident that t˙Td can be estimated by the second
eigenvector of X as:
t˙Td = c3λ2v
T
2 , w2 = u2/c3 (15)
where c2 and c3 are just proportionality factors interchangeable
between the dominant T wave and lead factors [34]. For later
use in section III-B2, we can note that equation (10) now
becomes
X ≈ λ1u1vT1 + λ2u2vT2 (16)
III. ECG REPOLARIZATION RISK MARKERS
A. ECG processing for repolarization analysis
Prior to computation of ECG repolarization indices, the
following four processing steps are commonly applied:
1) ECG filtering and preconditioning: This includes re-
moval of muscle noise, powerline interference and baseline
wander [3]. The ECG signal recorded in lead l is denoted by
xl(n) after filtering, while for the multi-lead filtered signal the
vector x(n) = [x1(n) . . . xL(n)]T is used.
2) QRS detection: Beat detection provides a series of
samples ni and its related RR intervals RRi = ni−ni−1, i =
0 . . . B, corresponding to the detected QRS complexes.
3) Wave delineation: Automatic determination of wave
boundaries and peaks is performed (see Fig. 3). The most rele-
vant points for repolarization analysis are the QRS boundaries,
T wave boundaries and T wave peak. Commonly computed
repolarization intervals, evaluated for each beat i, are the
QT interval (QTi, between QRS onset and T wave end), RT
interval (RTi, between QRS fiducial point and T wave peak),
T wave width (Twi ) and T wave peak-to-end (Tpei ).
Different delineation approaches have been proposed in the
literature. Multiscale analysis based on the dyadic wavelet
transform, allowing representation of a signal’s temporal fea-
tures at different resolutions, has proved useful for QRS detec-
tion and ECG delineation [41]. Multi-lead delineation, either
based on selection rules applied to single-lead delineation
results or based on VCG processing, has shown improved
accuracy and stability [42].
4) Segmentation: A repolarization segmentation window
Wi, usually containing the ST-T complex, can be defined. The
beginning of the window can be set at fixed or RR-dependent
offsets from the QRS fiducial point or the QRS end. An align-
ment stage can be applied if synchronization is required. If an
N -sample window, Wi, beginning at sample nWi is defined for
each ith beat to contain its repolarization phase, the extracted
repolarization segment for the ith beat and lth lead can be
denoted as xi,l(n) = xl(nWi +n), n = 0, . . . , N−1. For multi-
lead analysis, the L×1 vector xi(n) = [xi,1(n), . . . , xi,L(n)]T
contains samples in the different leads.
B. ECG markers of spatial repolarization dispersion
In this section a review of ECG indices proposed in the
literature to assess spatial heterogeneity of ventricular repo-
larization is presented.
1) Dispersion of repolarization reflected on ECG intervals:
QT dispersion (QTd), computed as the difference between the
maximum and minimum QT values across leads, was proposed
to quantify ventricular repolarization dispersion (VRD) [43].
However, the relationship between QTd and VRD resulted
controversial [44], as has been shown to mainly reflect the
different lead projections of the T wave loop rather than any
other type of dispersion. As a result, QTd has not been further
considered as a VRD index.
6Fig. 6. Superposition of transmural potentials d(t − ρm) of each node (left A), the histogram of Δρ (left B) and the generated T waves for a large/low
range of RT , ρm (right A/B). Reproduced from [40].
In [45] isolated-perfused canine hearts were used to measure
QTd and T wave width, TW. VRD values were computed after
changing temperature, cycle length and activation sequence.
VRD, evaluated directly from recovery times of epicardial
potentials, was compared to TW and QTd and shown to be
strongly correlated with TW, but not with QTd. TW was also
confirmed as a VRD measurement in a rabbit heart model
where increased dispersion was generated by d-sotalol and
premature stimulation [46]. TW is a complete measure of
dispersion as evidenced on the ECG. When addressing the
problem of evaluating TW in recordings under ischemia [47],
which largely increases repolarization dispersion, the T onset
estimation can largely be affected by the ST elevation, making
TW estimation unreliable and then being Tpe a possibly better
option. Even if Tpe does not only reflect transmural dispersion
but may include also other ventricular heterogeneities (e.g.
apico-basal) [48], [49], it is still a marker of VRD that can be
quantified from the ECG.
Since ECG wave onsets and ends have interlead variability,
due to the different projections of the cardiac electrical activity,
and also individual lead measures are more easily affected by
noise, multi-lead criteria are some times preferred [50]. In this
way the estimated interval value includes electrical activity
recovered at the complete space represented by the lead set.
T wave onset can be measured as the earliest reliable T wave
onset across leads and T wave end as the latest reliable T
wave end across leads, obtained either by applying rules, as
proposed in [50] to quantify TW, or by VCG-based methods
[51].
2) Dispersion of repolarization reflected on T wave mor-
phology: Several indices have been proposed to describe
the T wave shape. They lie on the assumption that larger
dispersion in repolarization times results in a more complex
T wave shape. Some of these descriptors rely on PCA to
extract information from the T wave shape [52]. The total
cosine R-to-T, TCRT, is defined as the cosine of the angle
between the dominant vectors of depolarization and repo-
larization phases in a 3D loop and has been evaluated to
compare repolarization in healthy subjects and hypertrophic
cardiomyopathy patients [53]. If the original ECG has L leads
(xi(n) in vector notation), it is transformed to ωi(n) =[
ωi,1(n) ωi,2(n) . . . ωi,L(n)
]T
, as
ωi(n) = UTi xi(n), (17)
Fig. 7. R-to-T Angle (left) between repolarization and depolarization phases.
The Principal component-to-T angle (right) between a fix reference and the
repolarization, Adapted from [46].
where Ui is the [L × L] matrix whose columns are the
eigenvectors of the i-th beat interlead autocorrelation matrix
(computed in the whole PQRST complex). Then, a 30-ms
window (NQRS samples) is defined centered on the QRS fiducial
point ni. The T wave peak position, ni,T, is estimated as the
position in the ST–T complex with maximum |ωi(n)|. Then,
the index TCRTi is defined by
TCRTi =
1
NQRS
NQRS−1∑
n=0
cos∠(ωi(n), ωi(ni,T)). (18)
If only tracking of the ventricular transmural gradient in
the same recording is needed, it is possible to estimate the
gradient of repolarization with respect to a fixed reference,
assuming that the direction of depolarization does not change
with repolarization heterogeneity. The proposed index is called
Total angle principal component-to-T, TPT, [46] see Fig.7. The
reference u can be taken to be the unitary vector in the first
principal component direction, yielding
TPTi = ∠(u, ωi,D(ni,T)). (19)
Total morphology dispersion, TMD, is an index computed
by selecting the first three principal components of the ECG
(assumed to be the dipolar components) and reconstructing
the signal in the original leads after discarding the rest
of components. Splitting the eigenvectr matrix as Ui =[
Ui,3 Ui,L−3
]
and applying
xˆi(n) = Ui,3UTi,3xi(n), (20)
the ”dipolar” signal xˆi(n) is obtained. This signal is again pro-
cessed by SVD, but now defined only from the spatial correla-
tion of the ST–T complex, obtaining the transformation matrix
Uˇi. Now the matrix is truncated to its first two columns Uˇi,2
7(defining the main plane of variation of the repolarization) and
again a signal is reconstructed in the original lead set: xˇi(n) =
Uˇi,2UˇTi,2xˆi(n). Note that Uˇi,2 =
[
φi,1 ∙ ∙ ∙ φi,L
]T
, where
φi,l are 2 × 1 reconstruction vectors, which can be seen as
the direction into which the SVD-transformed signal has to
be projected to get each original lead in xˇi(n). For each pair
of leads l1 and l2 the angle between both directions is
αl1,l2(i) = ∠(φi,l1 , φi,l2) ∈ [0o, 180o], (21)
measuring the morphology difference between leads l1 and l2
(a small angle is associated with similar shape in both leads).
The non-normalized TMDi index is computed by averaging
these angles for all pairs of leads,
TMDi =
1
L(L− 1)
L∑
l1,l2=1
l1 6=l2
αl1,l2(i) (22)
reflecting the average repolarization morphology dispersion
between leads. In the original definition of TMD each φi,l was
multiplied by its corresponding eigenvalue, having a different
geometrical interpretation [53].
Other descriptors have been proposed, based on the dis-
tribution of the eigenvalues of the inter-lead repolarization
correlation matrix Rˆxi =
∑N−1
n=0 xi(n)x
T
i (n). Let us denote
the eigenvalues as λi,j , j = 1 . . . L , sorted in descending
order. The energy of the dipolar components is given by
the sum of three first eigenvalues, while the sum of the
rest of eigenvalues represents the energy of the non-dipolar
components. The T wave residuum, TWR is defined as
TWRi =
L∑
j=4
λi,j/
L∑
j=1
λi,j . (23)
and can be interpreted as the relative energy of the non-dipolar
components [44], [53]. This is based on the hypothesis that in
normal conditions, the ECG can be explained by the first three
components (dipolar components). When local repolarization
heterogeneities are present, the dipolar model does not hold
any longer and this is reflected in larger eigenvalues corre-
sponding to the non-dipolar components, thus increasing TWRi
values.
T Wave Uniformity, Tu, and T wave Complexity, Tc, defined
as
Tui = λi,1/
L∑
j=1
λi,j , Tci =
L∑
j=2
λi,j/
L∑
j=1
λi,j = 1− Tui ,
(24)
are two other indices based on the same approach, aiming to
quantify the morphology of the ST-T complex loop [52]. A Tu
value close to one indicates that the ST-T complex loop is very
narrow and lies most of the time in the direction defined by
the first eigenvector of the SVD decomposition. On the other
hand, Tc close to one means that the loop is mainly contained
in a plane. The T wave complexity has also been alternatively
defined as the second to first eigenvalue ratio,
T ′ci = λi,2/λi,1, (25)
which in the framework of this review can be justified in the
light of equations (16) and (9): the larger λ2 is with respect
to λ1 (larger T ′c), the larger is the second order term in the
approximation (9) and, thus, the larger the RT dispersion
Δρ, therefore providing extra support for this measure as a
VRD index and illustrating an example of physiologically-
driven method development. The geometrical interpretation
of T ′c refers to the roundness of the loop (also denoted in
some works as T2,1). It has been shown that T ′c is higher in
patients with LQTS than in healthy subjects [52]. Also the
nonplanarity of the ventricular repolarization can be measured
as T3,1i = λi,3/λi,1 [47].
Finally, some T wave shape indices such as T wave ampli-
tude (TA), the ratio of the areas at both sides of the T peak
(TRA) and the ratio of the T peak to boundary intervals at both
sides of the T peak (TRT) (Fig. 3) have been proposed as risk
markers [54], grounded on the evidence that increased VRD
resulted in taller and more symmetric T waves [55].
The value of these makers to characterize VRD during
the first minutes of acute ischemia induced by percutaneous
coronary intervention (PCI) has also been studied [47]. It was
observed that changes in PCA-based morphology descriptors
were very dependent on the occluded artery, suggesting that
morphology changes are very affected by the direction of the
equivalent injury current. Most of the studied indices presented
a large inter-individual variability, pointing to the necessity of
using patient-adapted indices of relative changes.
C. ECG markers of temporal repolarization dispersion
ECG indices proposed in the literature as markers of tempo-
ral heterogeneity of ventricular repolarization are reviewed in
this section together with their links to ventricular arrhythmias.
The meaning of temporal is taken as it goes beyond a single
beat and includes information present in the evolution of the
index across several beats.
1) QT adaptation to HR changes: The QT interval is to a
great extent influenced by changes in HR [56]. A variety of
HR-correction formulas have been proposed in the literature to
compare QT measurements at different HRs [57]. Prolongation
of the QT interval or of the corrected QT interval (QTc) have
been recognized in some studies as markers of arrhythmic risk
[58]. However, it is today widely acknowledged that QT or
QTc prolongation per se are poor surrogates for proarrhythmia
[28]. The most popular formula to correct the QT interval for
the effects of HR is Bazett’s formula (QTc = QT/
√
RR),
but evidences of large overcorrection at low HR and under-
correction at high HR have led to other formulas such as the
Fridericia formula (QTc = QT/RR1/3), with better clinical
acceptance today.
Importantly, under conditions of unstable HR, the QT hys-
teresis lag after HR changes needs to be taken into considera-
tion. The QT interval requires some time to reach a new steady
state following a HR change, with important information for
prediction of arrhythmias additionally found in this adaptation
time [59]. In the literature, QT hysteresis has been evaluated
under various conditions. In [60] the ventricular paced QT
interval was shown to take between 2 and 3 minutes to follow
8a change in HR, with the adaptation process presenting two
phases: a fast initial phase lasting for a few tens of seconds
and a second slow phase lasting for several minutes. In [59],
QT adaptation was analyzed after a provoked HR change or
after physical exercise and the QT hysteresis lag was of some
minutes.
The ionic mechanisms underlying QT interval rate adapta-
tion have been investigated with the techniques described in
section II-A and II-C [61]. The time for 90% QT adaptation in
simulations was of 3.5 min, in agreement with experimental
and clinical data in humans, see Fig. 8. APD adaptation was
shown to follow similar dynamics to QT interval, being faster
in midmyocardial cells (2.5 min) than in endocardial and
epicardial cells (3.5 min), with these times being in accordance
with experimental data in human and canine tissues [61], [62].
Both QT and APD adapt in two phases: a fast initial phase
with time constant of around 30 s, mainly related to the L-
type calcium and the slow delayed rectifier potassium current,
and a second slow phase of 2 min driven by intracellular
sodium concentration ([Na]i) dynamics. The investigations in
[61] support the fact that protracted QT adaptation can provide
information of increased risk for cardiac arrhythmias.
Fig. 8. A: left: simulated QT interval adaptation in human pseudo-ECG for
cycle length (RR) changes from 1000 to 600 ms and latter back to 1000 ms;
right: QT adaptation in human ECG recordings from 50 or 110 beats/min
in increments or decrements of 20, 40, and 60 beats/min. Time required
for 90% QT rate adaptation (t90) is presented. B: simulated pseudo-ECGs
corresponding to first (dotted line) and last (solid line) beats after RR decrease
(left) and RR increase (right). C: t90 values for simulated pseudo-ECGs and
clinical human ECGs. HR Acc, acceleration; Dec, deceleration; TP06, human
ventricular cell model developed in [14]. Reproduced from [61].
In view of previous findings, it is well motivated to intro-
duce a method to assess and quantify QT adaptation to sponta-
neous HR changes in Holter ECGs, in [63] applied to record-
ings of post-myocardial infarction (MI) patients. The method
investigates QT dependence on HR by building weighted
averages of RR intervals preceding each QT measurement.
The relationship between the QT interval and the RR interval
is specifically modeled using a system composed of a FIR filter
followed by a nonlinear biparametric regression function (see
Fig. 9). The input to the system is defined from the resampled
beat-to-beat RRi interval series (denoted by xRR(k), where
k is discrete time), the output is the resampled QTi interval
series (yQT(k)), and additive noise v(k) is considered so as to
include e.g. delineation and modeling errors. The first (linear)
subsystem describes the influence of previous RR intervals on
each QT measurement, while the second (nonlinear) subsystem
is representative of how the QT interval evolves as a function
of the weighted average RR measurement, RR, obtained at
the output of the first subsystem.
xRR(k)- h zRR(k)- g(. ,a) - h+ yQT(k)?v(k)
Fig. 9. Block diagram describing the [RR, QT ] or or [RR,Tpe] relationship
consisting of a time invariant FIR filter (impulse response h) and a nonlinear
function gk(., a) described by the parameter vector a. v(k) accounts for the
output error. Reproduced from [63].
The global input-output relationship is thus expressed as:
yQT(k) = g(zRR(k), a) + v(k) , (26)
where
zRR(k) =
[
1 zRR(k)
]T = [1 hT xRR(k)]T . (27)
In the above expressions,
xRR(k) =
[
xRR(k) xRR(k − 1) . . . xRR(k −N + 1)
]T
, (28)
is the history of RR intervals, h =
[
h0 . . . hN−1
]T is the
impulse response of the FIR filter and g(∙) is the regression
function parameterized by vector a =
[
a0 a1
]T (see [63]
for a list of used regression functions). Identification of the
unknown system is performed individually for each patient
using a global optimization algorithm. According to the results
in [63], the QT interval requires nearly 2.5 minutes to follow
HR changes, in mean over patients, although both the duration
and profile of QT hysteresis are found to be highly individual.
As previously commented for the results reported in [61], the
adaptation process is shown to be composed of two distinct
phases: fast and slow.
The methodology described in [63] has been subsequently
extended in [64] to describe temporal changes in QT depen-
dence on HR, i.e. to account for possibly different adaptation
characteristics along each recording. The linear and nonlinear
subsystems used to model the QT /RR relationship are then
considered to be time-variant. An adaptive approach based on
the Kalman Filter is used in [64] to concurrently estimate the
system parameters. It has been shown that QT hysteresis can
range from a few seconds to several minutes depending on the
magnitude of HR changes along a recording.
The clinical value of investigating QT interval adaptation to
HR as a way to provide information on the risk of arrhythmic
complications has been shown in a number of studies in
the literature, as for instance [65]. In [66] 24-hour Holter
recordings of post-MI patients are investigated by using the
method described in [63]. The authors concluded that QT/RR
analysis can be used to assess the efficacy of antiarrhythmic
drugs.
2) QT variability: Other factors apart from HR contribute
to QT modulation and their study has been suggested to
provide clinically relevant information [67]. In addition to
ANS action on the SA node, the direct ANS action on
ventricular myocardium also alters repolarization and, thus,
9the QT interval [68]. Elucidation of the direct and indirect
effects of ANS activity on QT may help assessing arrhythmia
susceptibility [69].
QT variability (QTV) refers to beat-to-beat fluctuations of
the QT interval and can be quantified in the time or the
frequency domain. QTV is usually adjusted by HR variability
(HRV) to assess direct ANS influence on the ventricles. In
[70] QT variations out of proportion to HR variations were
assessed by considering the following log-ratio index:
QTV I = log10
[ QTv/QT 2m
HRv/HR2m
]
, (29)
where QTm and QTv denote mean and variance of the QT
series and HRm and HRv denote mean and variance of
the HR series. In [71] QTV was evaluated by standard time
domain indices like SDNN, RMSSD or pNN50, applied to
the QT series; also, QTV was evaluated in the frequency
domain by computing the total power as well as the power in
different frequency bands. Other studies have assessed beat-to-
beat variations in the shape or duration of ECG repolarization.
In [72] repolarization morphology variability was computed by
measuring the correlation between consecutive repolarization
waves; in [73] a wavelet-based method was proposed to quan-
tify repolarization variability both in amplitude and in time;
in [74] time domain measures that quantified variability of the
QT interval and of the T wave complexity were computed,
with complexity assessed using PCA.
Other approaches to assess repolarization variability use
parametric modeling [42], [75], [76]. While in [76] Porta et
al. investigate variability of the RT interval, in [42] Almeida
et al. explore QTV, and in [75] the variability from the R
peak to the T wave end (RTe) is considered. The use of RT
instead of QT avoids the need to determine the end of the T
wave, which is usually considered to be problematic. However,
due to the fact that the RT interval is shorter than the QT
interval, its variability is much reduced and, more importantly,
the information provided by RT variability and QTV has been
shown to be different in certain populations, such as in patients
with cardiovascular diseases [77]. In relation to this, recent
studies in the literature have shown that the interval between
the apex and end of the T wave possesses variability that is
independent from HR and which can provide clinically useful
information to be used for arrhythmic risk stratification [78].
The methodology described in [42] considers a linear para-
metric model to quantify the interactions between QTV and
HRV, being applicable under steady-state conditions. The type
of environments for analysis is, thus, substantially different
from those considered in section III-C1, in which QT interval
adaptation was investigated after possibly large HR changes.
In [42] as much as 40% of QTV was found not to be related
to HRV in healthy subjects. However, it should be noted that
nonlinear effects were not considered in the analysis.
Increased repolarization variability has been reported under
conditions predisposing to arrhythmic complications. Using
the above described QTVI index, elevated variability has
been reported in patients with dilated cardiomyopathy and in
patients with hypertrophic cardiomyopathy, as compared with
age-matched controls [79]. In [71] increased QTV in hyper-
trophic cardiomyopathy patients was also found using standard
time and frequency domain variability indices. Additionally,
higher levels of repolarization variability (either in shape or
duration) were found in LQTS patients [73], [74].
In patients presenting for electrophysiological testing, QTVI
was significantly higher in the subgroup of those who had
aborted SCD or documented VF [80]. In [81] increased QTVI
was shown to be an indicator of risk for developing arrhythmic
events (VT or VF) in post-MI patients. The association be-
tween increased repolarization variability and risk for VT/VF
was also shown in [80] for post-MI patients with severe left
ventricular (LV) dysfunction. In [75] an index quantifying
autonomic control of HR and RTe was shown to separate
symptomatic LQTS carriers from asymptomatic ones and
controls.
Investigating the causes and modulators of the clinically
observed, and eventually measured, temporal and spatial vari-
ability in ventricular repolarization is a challenging goal. The
use of combined experimental and computational approaches
can be a useful tool for such investigations [82]. In [83], [84]
and [85] it was hypothesized that fluctuations in ionic currents
caused by stochasticity in ion channel behavior contribute to
variability in cardiac repolarization, particularly under patho-
logical conditions. Also it was postulated that electrotonic
interactions through intercellular coupling act to mitigate spa-
tiotemporal variability in repolarization dynamics in tissue, as
compared to isolated cells. The approaches taken in [83], [84]
and [85] combine experimental and computational investiga-
tions in human, guinea pig and dog. Multiscale stochastic
models of ventricular electrophysiology are used, bridging
ion channel numbers to whole organ behavior. Results show
that under physiological conditions: i) stochastic fluctuations
in ion channel gating properties cause significant beat-to-
beat variability in APD in isolated cells, whereas cell-to-cell
differences in channel numbers also contribute to cell-to-cell
APD differences; ii) in tissue, electrotonic interactions mask
the effect of current fluctuations, resulting in a significant
decrease in APD temporal and spatial variability compared
to isolated cells. Pathological conditions resulting in gap
junctional uncoupling or a decrease in repolarization reserve
uncover the manifestation of current noise at cellular and
tissue level, resulting in enhanced ventricular variability and
abnormalities in repolarization such as afterdepolarizations
and alternans.
Also it is worth noting that temporal QT interval variations
may differ between recording leads due to the presence of
local repolarization heterogeneity in the ECG signals. Lead-
specific respiration effects or other types of noises can also
have an effect. Respiration may influence QTV through APD
modulation in ventricular myocytes [86], in particular during
respiratory sinus arrhythmia [87] and by measurement artefacts
in single ECG leads due to cardiac axis rotation, which can
be compensated for by using careful methodological designs
where the rotation angles introduced by respiration are taken
into account [51]. Ventricular repolarization is also modulated
by e.g. mechanoelectrical feedback in response to changes in
ventricular loading [88].
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D. ECG markers for characterization of spatio-temporal re-
polarization dispersion
1) T wave alternans: TWA, also referred to as repolariza-
tion alternans, is a cardiac phenomenon consisting on as a
periodic beat-to-beat alternating change in the amplitude or
shape of the ST-T complex, see Fig. 10.
Fig. 10. An example of T wave alternans. The alternating behavior between
two different T wave morphologies is particularly evident when all T waves
are aligned in time and superimposed, as displayed on the middle panel (b).
In (c) the alternanting waveform is amplified. Adapted from [89].
Although macroscopic TWA had been sporadically reported
since the origins of electrocardiography, it was not until the
generalization of computerized electrocardiology that it was
possible to detect and quantify subtle TWA at the level of
several microvolts [90]. Since then, TWA has been shown to
be a relatively common phenomenon, usually associated with
electrical instability. Therefore, it has been proposed as an
index of susceptibility to ventricular arrhythmias.
The presence of TWA has been widely validated as a marker
of SCD risk. A comprehensive review on physiological basis,
methods and clinical utility of TWA can be found in [91],
while the ionic basis of TWA has already been presented in
section II-B1.
In most patients, increased HR is necessary to elicit TWA.
Accordingly, measurement and quantification of TWA usually
require the elevation of HR in a controlled way (usually by
pacing or most commonly during exercise or pharmacological
stress tests). It is interesting to note that unspecific TWA has
been found at high HR in healthy subjects [92]. Thus, in order
to be considered as an index of increased risk of SCD, it is
usually considered that TWA should be present at HR below
110-115 bpm.
From the signal processing viewpoint, TWA analysis should
be considered a joint detection-estimation problem [90]. The
presence or absence of this phenomenon (i.e., a detection
problem) is often the only information considered and most
studies consider just the presence of TWA, regardless of its
magnitude, as a clinical index. However, the magnitude of
the observed TWA (i.e., an estimation problem) may also be
relevant, as it has been shown that increasing TWA magnitude
is associated with higher susceptibility to SCD [93]. Patterns of
variation in the TWA magnitude can be seen in three domains:
the distribution of alternans within the ST-T segment, the time
course of TWA and the distribution of TWA in the different
recorded leads.
The distribution of alternans within the repolarization in-
terval is normally overlooked, as a global measurement for
the whole ST-T segment (e.g. the maximal or the average
TWA amplitude) is usually given. However, some authors
have quantified the location of TWA, finding that it was more
specific for inducible VT when it was distributed later in the
ST-T segment [94]. Early TWA has been associated with acute
ischemia, although different locations have been noticed as a
function of the occluded artery [95]. Recent works have also
focused on the delay of the alternant wave with respect to the
T wave, defining a physiological range for this delay [96].
As TWA is a transient phenomenon, it must be quantified
locally, which is usually done using an analysis window with a
fixed width in beats. The time course of TWA can be tracked
by moving the analysis window. In stress tests, changes in
TWA amplitude are usually determined by changes in HR.
Therefore, the TWA time course is usually related with HR
changes. In stress tests, a set of rules involving the HR at which
TWA appears and the episode duration has been proposed to
determine the outcome of the TWA test [97]. The time course
of TWA magnitude with respect to the onset of ischemia and
reperfusion has been studied in the first minutes of acute
ischemia, both in a human model (with ischemia induced by
PCI) [95] and in animals [98]. However, at present, whether
temporal patterns in TWA can be clinically useful for risk
stratification is unknown [99].
The TWA magnitude distribution among the different leads
have been studied during acute ischemia [95] and in post-
MI patients [100], showing different patterns according to
the affected region of the myocardium, with higher amplitude
TWA measured in leads close to the diseased areas.
a) Single-lead alternans detection: A general model for
TWA analysis represents the ST-T complex of the ith beat in
the lth lead as
xi,l(n) = si,l(n)+
1
2
ai,l(n)(−1)i+vi,l(n), n = 0, . . . , N−1 (30)
where si,l(n) is the average ST-T complex, ai,l(n) is the
alternant wave, and vi,l(n) is a noise term. Assuming that
both si,l(n) and ai,l(n) vary smoothly from beat to beat,
the average ST-T complex can be easily cancelled out just
by subtracting to each beat the ST-T of the previous beat
yi,l(n) = xi,l(n) − xi−1,l(n), which is, according to the
model yi,l(n) = ai,l(n)(−1)i + wi,l(n), with wi,l(n) =
vi,l(n)− vi−1,l(n).
As described before, an analysis window must be defined
for TWA analysis, assuming that the TWA wave is essentially
constant within the beats included and shifting the window to
cover the whole available signal. Let us consider a window
of K beats. For each possible position of the window (e.g.,
when centered at the jth beat) the TWA analysis algorithm
must decide whether TWA is absent (aj,l(n) = 0 for every n)
or present (aj,l(n) 6= 0) in the signal. This is usually done by
computing a detection statistic Zj,l quantifying the likelihood
that there is indeed TWA in the signal and comparing it to
some threshold. Besides, algorithms usually provide either an
estimate aˆj,l(n) of the alternant wave present in each lead of
the signal or a global TWA magnitude Aj,l, as, for instance, the
RMS of aˆj,l(n). Note that the time course and lead-distribution
of TWA is given by the variations of Zj,l and Aj,l with the
beat and lead indices, respectively.
The reader can find in [90] a comprehensive methodological
review of the techniques that have been proposed for TWA
detection and estimation. According to the TWA analysis
approaches, the authors classify all schemes as equivalent
to one of these signal processing techniques: the short-term
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Fourier transform (STFT), count of sign-changes and nonlinear
filtering.
Methods of the first class are based on the classical
windowed Fourier analysis, applied to beat-to-beat series of
synchronized samples within the ST-T complex. Evaluating the
STFT at 0.5 cycles per beat, we obtain the TWA component
at the n-th sample.
zj,l(n) =
∞∑
i=−∞
xi,l(n) w(i− j) (−1)i. (31)
As shown in [90], this process is equivalent to apply a linear
high-pass filter to the beat-to-beat series with subsequent de-
modulation. The width of the analysis window w(i) expresses
the compromise between accuracy and tracking ability of the
algorithm. The linearity of the STFT makes these methods to
be quite sensitive to artifacts or impulsive noise in the beat-
to-beat series. The widely used spectral method [101] belongs
to this class. It estimates additional frequency components to
have an estimation of the noise level. For detection, a TWA
ratio is defined and compared to a threshold. This makes the
method less sensitive to variations in the noise level, thus
reducing the risk of false alarms.
The second class includes methods quantifying TWA ac-
cording to the analysis of sign-changes in the detrended beat-
to-beat series [90]. These methods are quite robust against
impulsive noise and artifacts, but are easily affected by the
presence of other non-alternant components. The amplitude
information is also lost when using these techniques.
Methods in the third class use nonlinear time domain
approaches instead of the linear filtering or Fourier-based
techniques. The modified moving average method estimates
the ST-T complex patterns for the odd and even beats, using a
recursive moving average whose updating term is modified by
a nonlinear limiting function [102]. TWA is then estimated at
each beat as the difference between the odd and even estimated
ST-T complexes. The main difference with respect to linear
techniques arises when there are abrupt changes in the waves,
due to noise, artifacts or abnormal beats: then the nonlinear
function keeps the effect on the TWA estimate bounded.
However, the method is sensitive to noise level changes, as
it does not consider adaptation to the noise level.
The Laplacian likelihood ratio (LLR) uses a statistical
model approach, considering a signal model similar to (30),
where the noise term is modelled as a zero-mean Laplacian
random variable with unknown variance. The generalised
likelihood ratio test (GLRT) and the maximum likelihood
estimate (MLE) are used, respectively, for TWA detection
and estimation at each position of the analysis window [90].
The assumption of a heavy-tailed noise distribution makes the
method more robust to outiers in the beat-to beat series. The
MLE of the alternant wave is the median-filtered demodulated
beat-to-beat series [95]
aˆj,l(n) = median{yi,l(n)(−1)i}i∈Wj, (32)
where Wj is the analysis window centered at beat j. The
GLRT statistic is
Zj,l =
√
2
σˆj,l
N−1∑
n=0
 ∑
i∈Wj
∣∣yi,l(n)∣∣− ∣∣yi,l(n)− aˆj,l(n)(−1)i∣∣
 , (33)
where σˆj,l = 1√2NL
N−1∑
n=0
∑
i∈Wj
∣∣yi,l(n)− aˆj,l(n)(−1)i∣∣ is an
estimation of the noise standard deviation. It can be proved
that the probability of a false alarm with this scheme does
not depend on the noise level. This TWA detector has also
been tested and successfully applied on invasive EGM signals
[103].
Although all these methods are usually applied on a lead-
by-lead basis, works using a multi-lead strategy suggest that
improved performance can be achieved by jointly processing
all the available leads, taking advantage of the different inter-
lead correlation of TWA and noise components [104].
b) Multi-lead alternans detection: Methodological ap-
proaches for multi-lead alternans detection have been pre-
sented in the literature, which integrate all the available
leads in such a way that the alternans is reinforced, making
subsequent TWA detection more robust.
We present here two multi-lead approaches [104], one based
on πCA (multi-πCA) [105] and another one based on PCA
(multi-PCA) [89]. Both approaches follow a general scheme
whose main stages are: preprocessing, signal transformation,
TWA detection, signal reconstruction and TWA estimation
(Fig. 11). The difference between multi-PCA and multi-πCA
is the way to perform the signal transformation (and recon-
struction).
Fig. 11. Block diagram of the general TWA multi-lead analysis scheme.
Blocks in bold line are the ones used in the single-lead scheme, in which
Y = X = X˜. Adapted from [104].
Signal preprocessing: After determining QRS positions and
removing baseline wander, the ECG signal can be low-pass
filtered and decimated to a sampling frequency of Fs≥30,
thus removing off-band noise while keeping TWA frequency
components [106]. In each beat, an interval of 350 ms (the
ST-T complex, corresponding to the N samples referred in
(30)) is selected for TWA analysis. In vector notation, the ST-
T complex presented in eq. (30) is denoted as
Xi =[xi,1, . . . ,xi,L]T , xi,l =[xi,l(0), . . . , xi,l(N−1)]T (34)
where for each beat i, matrix Xi is built with the ST-T
complexes from all leads (xi,l, l=1,...,L).
The data matrix X is then constructed by concatenating the
matrices Xi for the K beats in the analysis window,
X =
[
X0 X1 . . . XK−1
] (35)
and finally the matrix X(m) is constructed as
X(m) =
[
Xm Xm+1 . . . Xm+K−1
] (36)
which is equivalent to X, but shifting the analysis window m
beats forward.
Signal transformation: The aim of this stage is to apply a
linear transformation to the signal Y = ΥTX that improves the
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detectability of TWA by exploiting the information available
in the multi-lead ECG (see Fig. 12).
Input signal Transformed signal after PCA Transformed signal after πCA
m
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Fig. 12. (a) Eight independent leads of a real 12-lead ECG where TWA of
200 μV was artificially added. TWA is invisible to the naked eye due to noise
and artifacts. (b) Signal in (a) after PCA transformation. TWA is now visible
in the transformed lead T2 through exaggerated oscillations in the amplitude
of the T wave. (c) Signal in (a) after πCA transformation. TWA is clearly
visible in transform lead T1. Reproduced from [104].
In order to obtain a suitable transformation matrix Υ the
average ST-T complexes are canceled out by subtracting the
previous complex from each complex x′i,l = xi,l − xi−1,l.
These detrended beats x′i,l are used to build the matrices X
′
and X(m)′ as in (35) and (36). Note that X′ and X(m)′ now
contain K − 1 beats. The transformation matrix Υ can be
obtained as described in the following paragraphs. Note that
considering the identity transformation matrix, the multi-lead
scheme reduces to a single-lead scheme, handling each lead
independently throughout the detection/estimation process.
Principal Component Analysis: The detrended signal x′i,l is
a zero-mean random vector whose spatial correlation can be
estimated as
RX′ =
1
(K − 1)N X
′
X
′T . (37)
The PCA transformation matrix is obtained by solving the
eigenvector equation for matrix RX′
RX′Υ = ΥΛ (38)
where Λ is the diagonal eigenvalue matrix, where eigenvalues
are sorted in descending order, and Υ is the corresponding
orthonormal eigenvector matrix. The transformation defined
by matrix Υ is then applied to the original data matrix X to
obtain the transformed matrix
Y = ΥTX (39)
whose lth row (lth transformed lead) contains the lth principal
component of X. Fig. 12(b) shows the PCA transformation of
the input signal in (a).
Periodic Component Analysis: The aim of this technique is
to find a linear combination of the available leads y′Ti =
wTX′i enhancing the 2-beat periodicity corresponding to TWA
(equivalent to a frequency of 0.5 cycles per beat). The desired
weight vector is obtained by minimizing
²(w, 2) =
∑K−1
i=0
∥∥∥y′i+2 − y′i∥∥∥2∑K−1
i=0
∥∥y′i∥∥2 (40)
As shown in [105], (40) can be rewritten as
²(w, 2) =
wT AX′ (2)w
wT RX′w
(41)
where RX′ is defined in (37) and AX′ (2) is the spatial
correlation of
(
X(2)′ − X′
)
, which can be estimated as
AX′ (2) =
1
(K − 1)N
(
X(2)
′ − X′
)(
X(2)
′ − X′
)T
. (42)
The weight vector w minimizing (41) is the generalized eigen-
vector associated with the smallest generalized eigenvalue of
the matrix pair (AX′ (2),RX′ ) [105]. Generalizing this result,
the complete transformation matrix Υ can be defined as the
matrix whose columns are the generalized eigenvectors of
(AX′ (2),RX′ ) ordered in ascending order of magnitude of
their associated eigenvalues. In this way, the first row of the
transformed data matrix Y = ΥTX contains the most periodic
combination of leads (i.e. it is the transformed lead where
TWA - if present - is more easily detectable). Fig. 12(c) shows
the πCA transformation of the signal in (a).
TWA detection: After transforming the signal, single-lead
TWA detection is performed individually on each row of the
transformed signal Y applying the LLR method [95] described
in equation (33). As a result, the decision for lead l will be
dl = 1 if TWA is present in the lth transformed lead, and
dl = 0 otherwise. The multi-lead TWA detection is positive
if detection is at least positive in one transformed lead (‘OR’
block in Fig. 11), and negative otherwise.
Signal reconstruction: To allow a better clinical interpretation,
it is important to have TWA measured in the original lead set.
For that purpose, a reconstructed signal in the original leads
can be obtained, taking only those transformed leads where
TWA was detected to be present. A matrix ΥTR is obtained
by replacing with zeros the columns of Υ corresponding to
leads without TWA (dl = 0), thus discarding non-alternant
components. The reconstructed signal is then obtained as
X˜ = ΥTRY. (43)
TWA estimation and clinical indices: The MLE for Laplacian
noise (32) can be applied individually to each reconstructed
lead l to estimate the TWA waveform, aˆj,l(n). A global
amplitude of TWA (Aj,l) can finally be defined as the RMS
of aˆj,l(n).
From these values clinical indices need to be derived,
particularly when long term recordings are processed [107].
Some indices reflect the average amplitude of TWA and others
quantify the maximum TWA amplitude in specific segments
under study. An index of the former type is described as index
of average alternans (IAA) and their corresponding versions
after restriction to a specific interval for a HR value X are
described as HRrestricted indices of average alternans (IAAX ),
all of them proposed in [107]. IAA was computed as the
average of all Valt measured in 128-beat data windows during
the 24-hour period, thus reflecting the average TWA activity.
For instance, a 24-hour ECG presenting TWA for 5% of the
time with an amplitude of 60 μV would have an IAA=3
μV. IAAX values (X= {70, 80, 90, 100, 110} beats/min)
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were computed in a similar way, but considering only those
Valt measured in segments with average HR ranging from
X-10 to X beats/min. Therefore IAA90 reflects the average
TWA activity at HR between 80 and 90 beats/min in 24
hours. Clinical studies where these multi-lead techniques have
already being applied can be found in [107] and [108].
Finally, a note of caution: in stress test recordings, the
running/pedaling rate can overlap with the alternans rate when
the HR doubles the running/pedaling rate [109], e.g a cadence
of 65 rpm could create alternans-like artifacts at a HR of 130
bpm due to the synchronous body movements, which could
be erroneouly interpreted as electrical alternans [110].
c) T wave alternans in view of the biophysical modeling:
ECG repolarization alternans, as mentioned before, can result
from AP instability, which can be measured as fluctuations in
the duration of the AP. This phenomenon can be introduced in
the biophysical modeling already introduced in section II-C to
gain insight into how this AP duration fluctuation is reflected
on the T wave morphology and thus improve interpretation or
design of TWA detection [111].
In the model in (5), ρm = ρ + Δρm, the dispersion
heterogeneity Δρm can be made explicitly dependent on i-
th beat and further split into
Δρm(i) = ϑm + ϕm(i) + (−1)i δm2 , (44)
where ϑm describes the spatial variation of the repolarization
times for a given subject (at a given HR), ϕm(i) reflects the
slight, physiological beat-to-beat differences in repolarization
times and δm accounts for alternans in the repolarization times
occurring between even and odd beats in node m.
The value of ϑm can be estimated for a given beat by solv-
ing the inverse electrocardiographic problem. ϕm(i) can be
seen as a noise term and approximated by a set of independent
zero-mean normal random variables, with standard deviation
σϕ. For simplicity, in the short term, the standard deviation σϕ
is considered to be invariant with time and across myocardial
regions. The term δm is also assumed to be constant within
the analysis window [111].
Note that changes in HR affect the terms in this model [111].
When HR increases, the APD shortens and ρ moves closer to
the onset of the beat, but it is also known that the T wave
becomes more symmetrical with increased HR, including its
area, while its amplitude decreases [112]. This would suggest
modifying Δρm(i). However, other studies have shown that
the T-peak to T-end interval is mostly independent from
HR at rest [112], even if contradictory results have also
been published [113], and that the maximal difference among
APDs measured in isolated Langendorff- perfused rabbit hearts
[114] did not change significantly throughout the range of
paced steady-state cycle lengths, suggesting a minor effect
of the HR on Δρm(i). Possibly the two effects coexist: (i)
a small reduction of the spatial dispersion of repolarization
with increasing HR and (ii) a modification with HR of the
shape of the TMP in phases 2 and 3 [111].
According to the first order approximation in equation (8),
X ≈ w1tTd , the T wave for lead l and beat i, is:
xi,l(t) = −td(t)
M∑
m=1
Al,m Δρm(i). (45)
By computing the difference between two consecutive T waves
xi+1,l(t)− xi,l(t) = −td(t)
M∑
m=1
Al,m [Δρm(i + 1)−Δρm(i)]
= −td(t)
M∑
m=1
Al,m [ϕm(i +1)−ϕm(i)+δm] (46)
where the assumption is made that the dominant T wave does
not change between the two beats. Repeating the process on
successive couples of beats and averaging the results, the
following expression is obtained:
E[xi+1,l(t)− xi,l(t)] = −td(t)
M∑
m=1
Al,m δm. (47)
Therefore, under this model, TWA depends on δm (alternans
in the myocytes’ repolarization times), but also on the domi-
nant T wave td(t). If regional alternans is considered, δm 6= 0
only for several nodes, while in the case of global alternans
this would occur in each node m. In both situations, and given
a set of δm, TWA also depends on the matrix A and thus varies
for different subjects and leads [111].
2) Repolarization dispersion by T-peak to T-end interval
dynamics: In section II-B1 we already mentioned that the
APDR curve, and the increase in its dispersion, is related
to greater propensity to suffer arrythmias (Fig. 13), there-
fore providing potentially relevant information for ventricular
arrhythmic risk stratification [25], [115]. Heterogeneities in
the ventricle lead to non-uniform restitution properties, which
makes APDR curves present spatial variations [116].
Quantification of APDR dispersion requires invasive tech-
niques [117]. A method has been proposed in [20] to indirectly
estimate dispersion in the dynamic APDR slopes by evaluating
the relationship between the Tpe and the RR interval under
different stationary conditions. The Tpe interval reflects differ-
ences in the time for completion of repolarization at different
ventricular regions. While some studies postulate that Tpe
measures transmural dispersion of repolarization [48], other
studies claim that Tpe includes additional heterogeneities, such
as apico-basal ones [49].
For ECG segments of stable HRs, the index Δα (see Fig.
5, bottom-left) is defined as:
Δ̂α
ECGs
=
ΔT dynpe
ΔRR
(48)
where “ECGs” indicates stable ECG segments, as required
in the dynamic protocol, at two different RR intervals, Δ at
the left hand side of (48) refers to a difference of restitution
slopes occurring at two regions, while both Δ at the right hand
side refer to beat interval differences associated with two RR
levels [20].
For ECG segments of unstable HR, computation of the
index Δα includes a methodology to compensate for the Tpe
hysteresis lag after RR changes. The model used to estimate
Tpe hysteresis is the same presented in Fig. 9 but replacing the
QT interval with the Tpe interval. The RR and Tpe series of
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Fig. 13. Left panel: Dynamic restitution curves of two cells representing
APD as function of RR. Right panel: Representation of the Tpe interval in
terms of APDs and delay of activation times (ΔAT ). Adapted from [20].
each recording are interpolated and resampled to a sampling
frequency of fs = 1 Hz. The length N of vector h was set
to 150 samples that correspond to 150 seconds, which widely
exceeds the Tpe memory lag [20]. Details on the optimization
algorithm used for parameter identification can be found in
[118].
After h and gk(., a) have been optimized, zRR(n) can be
used as a surrogate of the running RR series that would
generate a truly stationary period in the running repolarization
interval Tpe. [Tpe(i), zRR(i)] represents the Tpe interval and
the surrogate for the RR interval after Tpe hysteresis compen-
sation. The estimate of restitution dispersion derived in (48)
for stable HR segments can be replaced with the following
equation:
Δ̂α
ECGc
=
∂Tpe
∂zRR
∣∣∣∣
zRR=zˉRR
=
∂gk(zRR, a)
∂zRR
∣∣∣∣
zRR=zˉRR
(49)
with gk being the nonlinear function represented in Figure
9. The above expression has the advantage of avoiding the
need for stationary ECG segments. The superindex “ECGc”
indicates that the quantification is done by compensating for
the Tpe memory lag. This estimate is a robust alternative
to Δ̂α
ECGs (see Fig. 5 bottom-left). In (49), the derivative is
evaluated at the mean zRR value, zˉRR, of the analyzed ECG
recording.
Electrophysiological modeling and simulation has been used
to evaluate Δ̂α
ECGs
and Δ̂α
ECGc
as measurements of APDR
slope dispersion at tissue level (see Fig. 5, right) [20]. Elec-
trical propagation in a left ventricular 2D tissue has been
simulated using a human ventricular AP model [14] and
numerical integration as described in [119]. The 2D tissue slice
covers base to apex and endocardial to epicardial distances,
as illustrated in Fig. 5, top right panel. For details about the
simulation see [20]. APDR curves are computed following
dynamic pacing at different RR intervals. Simulated APDR
slope dispersion is denoted by ΔαSIM, which is computed as:
ΔαSIM =
∂APDdynlast
∂RR
− ∂APD
dyn
min
∂RR
(50)
where APDmin corresponds to the cell with the minimum
APD among those which are repolarizing at the T wave
peak instant (time instant when the maximum repolarization
gradient sum occurs) and APDlast is the APD of the last cell
to repolarize. Estimations of ΔαSIM are computed from pseudo-
ECGs using (48). Each pseudo-ECG evaluates the extracellular
potential at a sensor position (Fig. 5, bottom-right) [120]. The
corresponding estimation is:
Δ̂α
pECG
=
∂T dynpe
∂RR
(51)
where T dynpe represents the Tpe interval measured from the
pseudo-ECG under the dynamic protocol (see Fig. 14).
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Fig. 14. Top panel: simulated sequence of isochronic voltage representation
during steady-state pacing at 1000 ms. The position of the two cells corre-
sponding to APDmin, for the the T wave peak, and APDlast, for the T
wave end, are shown with a gray point. Bottom panel: derived pseudo-ECG.
Reproduced from [20].
The value of the index Δα for risk stratification has
been explored in different populations, as in patients who
developed TdP after sotalol administration [121], in patients
with hypertrophic cardiomyopathy [122] and in patients with
heart failure [123], where the prognostic value of Δα could
be corroborated in retrospective studies, and with the provided
information being complementary to that obtained from other
repolarization or autonomic indices measuring TWA (IAA
parameter) or heart rate turbulence (HRT).
3) Repolarization dispersion by biophysical model param-
eter estimation: VRD can account for heterogeneities in the
AP shape across the ventricular wall, but mainly reflects dif-
ferences in the APD. Taking the biophysical model presented
in section II-C as a starting point, a method has been proposed
in [34] to quantify this dispersion. One of the goals is to
show that VRD can be quantified by estimating the standard
deviation of the time instants ρm (named sϑ). This dispersion
includes two sources, one from the fact that AP activation
times are not synchronous at all nodes (see Fig. 6) and the
other one from the fact that APD is different at different sites
(nodes). Since it is known that the dispersion in activation time
instants is much smaller than the dispersion in the APDs, the
variance in ρm is assumed to be a valid surrogate for the
dispersion of the repolarization times.
In [34] a procedure is developed based on a stochastic model
for ρm. The RT associated with the mth node, introduced in
equation (5), can be expressed as explicitely depending on beat
i:
ρm(i) = ρ(i) + Δρm(i) = ρ(i) + ϑm + ϕm(i) (52)
where ρ(i) is the average RT , which may be different for
each beat i, and Δρm(i) ¿ ρ(i) is the dispersion with respect
to the average value (note that∑Mm=1 Δρm(i) = 0). Although
both terms are expected to depend on HR, the discussion in
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[34] is limited to the case of stationary HR. In this condition,
Δρm(i) is split into two terms, ϑm and ϕm(i), as shown in
(52). On the one hand, ϑm describes the spatial variation of
the RT s considering the sequence of repolarization, starting
from the apex of the ventricles. On the other hand ϕm(i)
accounts for the slight, physiological beat-to-beat differences
in RT s. As it will be later discussed, it is reasonable to
consider that, in general, ϕm(i) ¿ ϑm. If the distribution
of the RT s is affected by a pathological condition, this will
be reflected in the model by a change in ϑm, thus this is the
main index to be measured, while ϕm(i) can be seen as a
noise term affecting the measurements at every beat and can
be assumed to be independent of m and normally distributed
with variance σ2ϕ(i) (see [34] for details). Also independence
of ϕm(i) for different sites (m) and beats (i) is assumed. If
σ2ϕ(k) is constant among beats (specially in stable HR and
short time windows), the dependence on beat i can be dropped
and Δρm(i) v N (ϑm, σ2ϕ).
Linking the above described modeling with the lead factors,
w1 and w2, we have:
w1(l)= −
M∑
m=1
Al,mΔρm, w2(l) =
1
2
M∑
m=1
Al,mΔρ2m. (53)
By averaging in time, the mean and variance of w1(l) can be
calculated as:
E[w1(l)]=−
M∑
m=1
Al,mϑm, var[w1(l)]=σ2ϕ
M∑
m=1
A2l,m. (54)
Proceeding similarly with w2(l) and using the fact that∑M
m=1 Ai,m = 0, we have:
E[w2(l)] =
1
2
M∑
m=1
Al,m ϑ
2
m (55)
var[w2(l)] =
1
4
M∑
m=1
A2l,m var[Δρ2m]
=
σ4ϕ
2
M∑
m=1
A2l,m + σ
2
ϕ
M∑
m=1
A2l,mϑ
2
m (56)
where the equality E[Δρ4m] = ϑ4m + 6ϑ2mσ2ϕ + 3σ4ϕ has been
used. Defining the following ratio:
var[w2(l)
var[w1(l)]
=
σ2ϕ
2
+
∑M
m=1 A
2
l,m ϑ
2
m∑M
m=1 A
2
l,m
(57)
and doing some additional algebraic calculations [34]
M∑
m=1
A2l,m ϑ
2
m =
(
M∑
m=1
ϑ2m
M
)
︸ ︷︷ ︸
s2
ϑ
(
M∑
m=1
A2l,m
)
+
M∑
m=1
(
A2l,m−
M∑
m′=1
A2
l,m′
M
)(
ϑ2m−
M∑
m′=1
ϑ2
m′
M
)
︸ ︷︷ ︸
Cl
(58)
the ratio can be calculated as
var[w2(l)]
var[w1(l)]
=
σ2ϕ
2
+ s2ϑ +
Cl
M
M∑M
m=1 A
2
l,m
. (59)
Given that variability across time is supposed to be much
smaller than the spatial dispersion σ2ϕ ¿ s2ϑ and than Cl/M
can be seen as the covariance of the lth row of matrix A
with the spatial dispersion ϑm, which are not coherent, and
in addition equation (59) is normalized by the variance of the
elements in the l row of A, the V-index can be defined as:
Vl = std[w2(l)]
std[w1(l)]
≈ s2ϑ. (60)
This V-index turns out to be independent of l and represents
the VRD measurement proposed in [34]. Vl needs to be
estimated by calculating the lead factors w1 and w2, which
can be done as explained in section II-C.
This modeling has several approximations and assumptions
that may question to what extent relevant clinical information
may be missed when computing the V-index. In [124], with
the aim to check for this, known dispersion was simulated in
a tissue model. The biophysics-based V-index was computed
and the results compared to the simulated dispersion. It has
been proved that when the assumptions are relatively well
satisfied, the V-index is a good approximation, but when the
independence assumption between nodes and time is lost,
high bias appears between estimation and reality. In some
circumstances this can be overcome with some modifications
of the V-index presented in [124].
Clinical application of the index has already been explored
in [125], where increased dispersion of the repolarization
times, as measured by the V-index, was found in patients with
Chagas disease, being significantly correlated with the risk of
death in a univariate survival analysis. Already in the initial
study [34] it was shown that the index increases with sotalol
administration, known to increase VRD. Later in [126], the V-
index was studied under moxifloxacin administration, showing
a higher relative increase than the corrected QT interval.
The modeling here presented has been subsequently ex-
tended to analyze and correlate other T wave features with
VRD, including the QT interval, T wave variability and others
[40]. The V-index is the one that results in the highest
correlation to VRD. The QT interval is also highly correlated,
with the drawback that it requires precise delineation of the T
wave end, which is a problematic technical problem.
E. Summary of repolarization risk markers.
The repolarization markers presented all along this review
are summarized in the table I together with references to their
physiological background and clinical evaluation.
TABLE I
SUMMARY OF RISK MARKERS, REFERENCES TO THEIR PHYSIOLOGICAL
BACKGROUND AND CLINICAL EVALUATION.*AND REFERENCES THEREIN.
Marker class Physiological background Clinical evaluation
B1. Repolarization intervals [45], [46], [127] [47]
B2. T wave morphology [46], [52], [55] [47], [53], [54], [128]
C1. QT adaptation to HR [59], [60], [62], [61] [63], [65], [66]
C2. QT variability [84], [68], [69], [82] [70], [71], [72], [73]
[83], [85], [42], [76] [75], [77], [79], [80]
[81]
D1. T-wave alternans [91]*, [92], [95], [98] [91]*, [93], [107]
[23], [24] [108]
D2. Tpe dynamics [129], [130], [116], [117] [121] [122], [123]
[25], [48], [26], [20], [27]
D3. Repol. dispersion [29], [32], [34], [36] [125], [126]
biophysical model
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IV. CHALLENGES AND FUTURE PERSPECTIVES
In the previous sections, a catalog of techniques for as-
sessment of ventricular repolarization instability have been
presented, with emphasis in the description of recent ECG
processing developments.
It must be acknowledged, however, that most of the ECG
features presented here are only currently used in the context
of research studies and have not yet bridged the gap to
clinical routine. For instance, the left ventricular ejection
fraction is commonly the only metric considered to predict
the benefit from an ICD. In other studies evaluating drug-
induced ECG changes, the QT interval, or the heart rate-
corrected QT interval, is considered as the only marker to
assess pro-arrhythmicity, despite its well-known limitations.
Considering the six phases for the assessment of a novel risk
marker, presented by Hlatky et al. (1. Proof of Concept, 2.
Prospective validation, 3. Incremental value, 4. Clinical utility,
5. Clinical outcome and 6. Cost-effectiveness) [131], most of
the risk indices presented in this review have at most been
evaluated in studies that can be framed in phases 1 or 2,
performed in small, specific populations. For a risk marker to
become part of established clinical protocols, it must prove
not only to be capable of quantifying increased instability
or risk, but its capacity has to be large enough to change
clinical management procedures. This must be proved in large-
scale prospective trials, considering the cost-effectiveness ratio
(including not only the cost of the test, but also the cost of
patient management associated with its results). Bridging the
gap from scientific research to the clinics is the main challenge
in this area.
Considering that between 45-50% of SCD occur in the
general population (without known heart disease) [132] one
important challenge is to identify non-invasive markers that
can be measured in routine tests such as 10-s ECG or
standard Holter recordings. Taking into account the different
etiology and complexity of factors involved in SCD, it is also
important to consider the combination of different markers
that have been proved to be associated with risk separately
(possibly including also chemical and genetic biomarkers).
While some single non-invasive indices may have in their
own modest incremental value, combining indices quantifying
different physiological phenomena may provide more robust
prediction or help to discriminate between different types of
negative outcomes [123]. In the same manner as standardized
databases have helped in the development, validation and
comparison of computerized methods in electrocardiography,
the establishment of baseline risk models for common pa-
tient groups (including the general population) [133] and the
availability of ECG and clinical data from well-designed risk-
stratification-based trials would lead to more focused efforts
in risk stratification, accelerating the way to clinical impact.
Additionally, despite the widely acknowledged dynamic na-
ture of repolarization instability and arrhythmias, most studies
disregard this fact and consider just a measurement of a
specific risk marker at a single time point, and analyze its
ability to predict risk at some indefinite future time. Current
challenges to advance in risk stratification studies include as-
sessment of a marker’s ability to track variations in arrhythmic
risk (e.g. when monitoring the effects of drug treatments or
the evolution of cardiac diseases) as well as determination
of the time frame for arrhythmic complications that may
lead to SCD. Also, risk stratification would benefit from the
development of novel non-invasive ventricular repolarization
markers, for which a better understanding of the interaction
between substrate, triggers and modulators involved in SCD
is fundamental. Multi-scale computational modeling combined
with signal processing of cardiac electrical signals offer a
powerful tool to gain insight into SCD mechanisms and can
definitely help in the development of personalized non-invasive
clinical markers.
V. CONCLUSIONS
In this work, a review of technologies developed to quantify
ventricular repolarization dispersion from the ECG is pre-
sented. The review focuses on so-called physiologically-driven
model-based signal processing approaches. Some methods are
developed from basic descriptive ECG considerations, while
others come from either simplified or detailed biophysical
modeling of the ventricular myocardium. While some of the
presented methods aim at capturing stationary features, others
provide information regarding the dynamics of repolarization,
typically following HR variations. In any case, the final objec-
tive of the presented methodologies is its clinical impact and
this requires companion clinical studies where to assess their
utility. We firmly believe that combining clinical, experimental
and technological development plus the use of physiologically-
driven model-based signal processing approaches is a right
path to pursue the limits of SCD prediction from the ECG.
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